The startup develops a medical implant device that monitors endosseous implant osseointegration to enhance dental implant stability. This technology provides real-time data to surgeons, improving decision-making during procedures and increasing the success rate of implant surgeries.
Funding
$770K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Assessing dental implant stability relies on subjective methods, leading to uncertainty in determining the optimal time for prosthesis setup. This can result in longer healing times, increased failure rates, and complications for patients. Current methods lack the precision needed for reliable and objective evaluation of osseointegration.
Solution
WaveImplant's OsteoWave utilizes ultrasound technology to provide a quantitative assessment of dental implant stability. The system analyzes ultrasonic waves reflected at the interface between the implant and bone tissue, providing surgeons with a stability score. This score enables informed decisions regarding surgical procedures and loading times, aiming to improve implant performance and reduce healing times. The OsteoWave system consists of the OsteoWave device and the ProbeOne, an ultrasonic probe that screws directly into the implant.
Target Audience
The primary target audience includes dental surgeons seeking a more precise and objective method for assessing dental implant stability.
Features
- Ultrasound-based technology for evaluating primary and secondary dental implant stability
- ProbeOne: ultrasonic probe with magnetic connection to OsteoWave, designed for compatibility with various implant configurations
- Provides a quantitative stability score reflecting the implant's stability
- Semi-consumable ProbeOne device resistant to multiple autoclave cycles
- Dedicated screwing tool for controlled, low-torque ProbeOne insertion